Treatments on the horizon for myasthenia gravis
Complement inhibitor |
Zilucoplan |
Neonatal Fc receptor inhibitors |
Batoclimab |
Nipocalimab |
Rozanolixizumab |
B-lymphocyte depletion therapy |
Obinutuzumab |
Ofatumumab |
Ublituximab |
Blinatumomab |
Inebilizumab |
Cytokine inhibitor |
Tocilizumab |
Janus kinase inhibitors |
Ruxolitinib |
Baricitinib |
Tofacitinib |
Hematopoietic stem cell transplantation |
Chimeric antigen receptor T-cell therapy |